1.Imaging characteristics of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy carrying cysteine-altering or non-cysteine-altering NOTCH3 mutations
Journal of Apoplexy and Nervous Diseases 2026;43(2):140-144
Objective To investigate the imaging characteristics of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)carrying cysteine-altering versus non-cysteine-altering NOTCH3 mutations. Methods A retrospective analysis was performed for 19 patients with CADASIL who attended Department of Neurology,The Affiliated Hospital of Guizhou Medical University, among whom there were 16 patients with cysteine-altering mutations and 3 with non-cysteine-altering mutations, and PubMed database was searched to obtain 192 cases (158 patients with cysteine-altering mutations and 34 with non-cysteine-altering mutations). The impact of these two types of mutations on lesion distribution in the temporal pole and external capsule was analyzed. Results The cysteine-altering mutation group had a significantly higher risk of temporal pole lesions compared with the non-cysteine-altering mutation group (OR=2.99,95%CI 1.37‒6.51,P=0.006), and there was no significant difference in external capsule lesions between the two groups (OR=2.31,95%CI 0.75‒6.48,P=0.12). External capsule lesions were associated with age (OR=1.04,95%CI 1.01‒1.07, P=0.02).Sex showed no significant influence on lesion distribution(OR=1.72,95%CI 0.67‒4.67,P=0.27;temporal pole:OR=0.54,95%CI 0.27‒1.05, P=0.07). Conclusion Cysteine-altering NOTCH3 mutations are an independent risk factor for temporal pole lesions,while external capsule lesions are closely associated with age. This suggests that temporal pole lesions might be a specific imaging marker for cysteine-altering mutations, whereas external capsule lesions can reflect age-related disease progression.
2.Recommendations for the clinical use of anti-amyloid-β monoclonal antibody for Alzheimer's disease(2025)
Nan ZHI ; Jinwen XIAO ; Rujing REN ; Binyin LI ; Jintao WANG ; Jieli GENG ; Wenwei CAO ; Yaying SONG ; Hualong WANG ; Shuguang CHU ; Guoping PENG ; Jun LIU ; Xiaoyun LIU ; Fang YUAN ; Wen WANG ; Ronghua DOU ; Xia LI ; Ling YUE ; Wenshi WEI ; Xiaoling PAN ; Xiangyang ZHU ; Dian HE ; Weinü FAN ; Jingping SHI ; Nan ZHANG ; Hui ZHAO ; Qin CHEN ; Cuibai WEI ; Xiaochun CHEN ; Gang WANG
Journal of Chongqing Medical University 2025;50(9):1133-1140
In recent years,significant breakthroughs have been achieved in the immunotherapy for Alzheimer's disease.In line with global advancements,two anti-amyloid-β monoclonal antibodies have been approved and successfully launched in China for clinical use.Lecanemab and Donanemab were officially used in June 2024 and April 2025 in China,respectively.In order to standardize the rational and safe application of anti-amyloid-β monoclonal antibodies for Alzheimer's disease in China,this article integrates recom-mendations from the clinical trials and real-world experience from the author's team and domestic peers to further update the recom-mendations for the clinical use of anti-amyloid-β monoclonal antibody based on the 2024 version.It includes indications for therapy,pre-treatment evaluation and preparation,administration protocols and safety measures during treatment,and post-treatment monitor-ing strategies.
3.Research progress of Calpain in fibrotic diseases
Fudan University Journal of Medical Sciences 2025;52(6):897-902
Calpain-mediated fibrosis,a physiological tissue repair process that almost occurs in most of tissues and organs,is closely related to multiple cellular pathways and is widely involved in the progression of diseases.It is believed that the pro-and anti-fibrotic systems are dynamic regulated in vivo,so pathological organ fibrosis still may be controlled and even reversed.This review summarizes the latest researches on the role of Calpain family in different organ fibrosis and the intervention of Calpain inhibitor in fibrosis progression,aiming to providing a reference for the research of Calpain family in fibrotic diseases context.
4.Research progress of Calpain in fibrotic diseases
Fudan University Journal of Medical Sciences 2025;52(6):897-902
Calpain-mediated fibrosis,a physiological tissue repair process that almost occurs in most of tissues and organs,is closely related to multiple cellular pathways and is widely involved in the progression of diseases.It is believed that the pro-and anti-fibrotic systems are dynamic regulated in vivo,so pathological organ fibrosis still may be controlled and even reversed.This review summarizes the latest researches on the role of Calpain family in different organ fibrosis and the intervention of Calpain inhibitor in fibrosis progression,aiming to providing a reference for the research of Calpain family in fibrotic diseases context.
5.Skin metastasis along a pleural catheter with cutaneous metastatic lung adenocarcinoma:one case report
Han-Yu ZHANG ; Dian-Yu CAO ; Qiang WANG
Fudan University Journal of Medical Sciences 2024;51(1):133-138
There was a 61-year-old male patient with cutaneous metastatic lung adenocarcinoma inoculated along a thoracic drainage tube treated in Zhongshan Hospital,Fudan University.The duration of disease was over 2 weeks.The skin lesions were extensive and appeared as purplish red nodules ranging in size from mung bean to small walnut.The nodules were tough and solid,smooth in surface,with infiltration while without ulceration,pruritus or tenderness.The patient developed chest tightness and pain without obvious causes,dull pain in nature and less white sputum 6 weeks before the eruption,and then was diagnosed as malignant tumors of the left lung(poorly differentiated adenocarcinoma),cT1cN3M1c stage Ⅳ B(pleura,bone).Gene tests showed that epidermal growth factor receptor(EGFR)21 exon point mutation L858r,Ros1(-),anaplastic lymphoma kinase(ALK)(-),and physical status score(PS)of 0.The treatment was Dactinib 45mg once each day,supplemented the bone preservation therapy by ibandronic acid.As the patient's condition did not significantly improve and skin nodules increased,also the abdominal B-ultrasound examination showed that multiple metastases in liver,the treatment was changed to Ectinib hydrochloride tablets(Kemena)of 125 mg 3 times a day,combined with Crizotinib capsules(Secor)of 200 mg twice a day.Unfortunately,the patient has now been lost to follow-up.
6.Efficiency of different large language models in China in response to consultations about PCa-related perioperative nursing and health education
Xiao-Wen TAN ; Wen-Fang CHEN ; Na-Na WANG ; Hui-Yu LI ; Juan LI ; Yu-Mei CAO ; Meng-Qi ZHU ; Kun LI ; Ting-Ling ZHANG ; Dian FU
National Journal of Andrology 2024;30(2):151-156
Objective:To evaluate the efficiency of the four domestic language models,ERNIE Bot,ChatGLM2,Spark Desk and Qwen-14B-Chat,all with a massive user base and significant social attention,in response to consultations about PCa-related perio-perative nursing and health education.Methods:We designed a questionnaire that includes 15 questions commonly concerned by patients undergoing radical prostatectomy and 2 common nursing cases,and inputted the questions into each of the four language models for simulation consultation.Three nursing experts assessed the model responses based on a pre-designed Likert 5-point scale in terms of accuracy,comprehensiveness,understandability,humanistic care,and case analysis.We evaluated and compared the performance of the four models using visualization tools and statistical analyses.Results:All the models generated high-quality texts with no mis-leading information and exhibited satisfactory performance.Qwen-14B-Chat scored the highest in all aspects and showed relatively sta-ble outputs in multiple tests compared with ChatGLM2.Spark Desk performed well in terms of understandability but lacked comprehen-siveness and humanistic care.Both Qwen-14B-Chat and ChatGLM2 demonstrated excellent performance in case analysis.The overall performance of ERNIE Bot was slightly inferior.All things considered,Qwen-14B-Chat was superior to the other three models in con-sultations about PCa-related perioperative nursing and health education.Conclusion:In PCa-related perioperative nursing,large language models represented by Qwen-14B-Chat are expected to become powerful auxiliary tools to provide patients with more medical expertise and information support,so as to improve the patient compliance and the quality of clinical treatment and nursing.
7.Temporal trend of the global prevalence rate of tension-type headache in children and adolescents in 1990-2021
Ling-Zi YAO ; De-Nan JIANG ; Jing WU ; Guang-Dian SHEN ; Jin CAO ; Si-Qing CHENG ; Shi-Yi SHAN ; Ze-Yu LUO ; Jia-Li ZHOU ; Pei-Ge SONG
Chinese Journal of Contemporary Pediatrics 2024;26(10):1058-1065
Objective To investigate the prevalence of tension-type headache(TTH)in children and adolescents aged 0-19 years globally in 1990-2021,and to provide a basis for the prevention and treatment of TTH.Methods Based on the Global Burden of Disease Study data,the age-standardized prevalence distribution of TTH and its changing trend were analyzed among the children and adolescents aged 0-19 years,with different sexes,age groups,sociodemographic index(SDI)regions and countries/territories.Results The age-standardized prevalence rate(ASPR)of TTH in children and adolescents aged 0-19 globally in 2021 was 17 339.89/100 000,which was increased by 1.73%since 1990.The ASPR in females was slightly higher than that in males(1990:17 707.65/100 000 vs 16 403.78/100 000;2021:17 946.29/100 000 vs 16 763.09/100 000).The ASPR in adolescence was significantly higher than that in school-aged and preschool periods(1990:27 672.04/100 000 vs 10 134.16/100 000;2021:28 239.04/100 000 vs 10 059.39/100 000).Regions with high SDI exhibited a higher ASPR than the other regions,with significant differences in prevalence rates across different countries.From 1990 to 2021,there was a slight increase in global ASPR,with an average annual percentage change(AAPC)of 0.06%.Females experienced a smaller increase than males based on AAPC(0.04%vs 0.07%).There was reduction in ASPR in preschool and school-aged groups,with an AAPC of-0.02%,while there was a significant increase in ASPR in adolescence,with an AAPC of 0.07%.ASPR decreased in regions with low-middle and low levels of SDI,with an AAPC of-0.02%and-0.04%,respectively,while it increased in regions with middle SDI,with an AAPC of 0.24%.Conclusions There is a consistent increase in the ASPR of TTH in children and adolescents aged 0-19 years globally,with significant differences across sexes,age groups,SDI regions and countries/territories.
8.Application progress of exergames in health interventions for the elderly
Xi CHEN ; Hongting NING ; Shuang WU ; Lina WU ; Dian JIANG ; Yifei CHEN ; Zeng CAO ; Hui FENG
Journal of Central South University(Medical Sciences) 2024;49(4):534-540
With the aging population in China,health issues among the elderly are becoming increasingly prominent,leading to a rapidly growing demand for health interventions for the elderly.Exergames are one of the important emerging methods in the field of health interventions for the elderly,widely used and yielding positive results.While research on exergames is well-established abroad,it is still in its infancy in China,lacking reports on the types,interaction forms,intervention content,application status,and effectiveness of exergames.Exergames are suitable for widespread use among the elderly in China,and there is a need to accelerate the development and application of exergames in the field of health interventions for the elderly in China.
9.RHD Genotyping Characteristics of RhD-Negative Blood Donors in Wuhu Area
Meng-Nan LI ; Zhen-Jun DU ; Jing-Wen LIU ; Rui ZHANG ; Yuan WANG ; Dian-Ming CAO ; Ji-Chun TAO ; Lu-Chen ZOU ; Hui HUANG ; En-Tao SUN
Journal of Experimental Hematology 2024;32(5):1531-1538
Objective:To investigate the molecular mechanism and distribution characteristics of RhD negative phenotypes in Han population of blood donors in Wuhu city.Methods:A total of 210 RhD-samples from August 2021 to August 2022 were screened by serological test and collected from Wuhu Central Blood Station for the voluntary blood donor population.Exons 1 and 10 of the RHD gene were amplificated by PCR to determine whether the samples had the RHD gene.Exons 1-10 of the RHD gene were amplificated by PCR and zygosity analysis were performed in 82 samples containing D gene,and Sanger sequencing was performed on 55 samples containing all RHD exons to determine the genotype.Results:Among 210 RhD-specimens,128 cases(60.38%)had RHD gene deletion.27 cases had partial exons of RHD,including 2 cases with RHD*DVI.3/RHD*01N.01,24 cases with RHD*01N.04/RHD*01N.01,and 1 case with RHD-CE(2-10)/RHD*01N.01.55 cases had retained all of 10 exons,including 4 cases with RHD*01/RHD*01N.01,6 cases with RHD*15/RHD*01N.01,1 case with RHD*01W.72/RHD*01N.01,1 case with RHD*15/RHD*01EL.01,39 cases with RHD*01EL.01/RHD*01N.01,and the remaining 4 cases were determined to have no RHD gene deletion by zygosity analysis and sequencing showed the presence of 1227G>A mutation loci.Conclusion:There is polymorphism in the molecular mechanism of RhD-D gene in Wuhu blood donor population,among which RHD*01EL.01 and RHD*15 are the main variants in this region.The results of this study provide a theoretical basis for RhD blood group identification and clinical blood transfusion in this region.
10.Clinical study of Shenbao tablet in the treatment of kidney-yang deficiency syndrome
Xiu-Dian LI ; Ping CHENG ; Zhe CAO ; Qiong HUA ; Xiang-Xin MENG ; Qing-Gang ZHOU
The Chinese Journal of Clinical Pharmacology 2024;40(4):524-528
Objective To evaluate the efficacy and safety of Shenbao tablet in the treatment of kidney-yang deficiency syndrome.Methods Patients with kidney-yang deficiency syndrome,will were treated with Shenbao Tablets orally,3 tablets once,3 times a day,and the course of treatment was 56 days or 84 days,depending on the condition.By comparing the clinical efficacy,the changes of symptom scores and syndrome scores before and after treatment,and symptoms remission time,the effectiveness of Shenbao tablet in the treatment of kidney-yang deficiency syndrome was evaluated.The safety was evaluated by adverse reactions.Results There were 339 patients in the 56-day group and 345 patients in the 84-day group.After treatment,the clinical effective rates of the 56-day group and the 84-day group were 91.74%and 97.97%,respectively,and the difference was statistically significant(P<0.05).In the 56-day group and the 84-day group,the excellent rate were 58.41%and 59.13%,clinical control rates were 18.58%and 27.54%,and the progress rates were 14.75%and 11.30%,respectively.After treatment,the symptom scores of kidney-yang deficiency syndrome were significantly reduced respectively within both groups(P<0.05).In the 56-day group and the 84-day group,the nocturia scores of were 0.89±1.27 and 0.60±1.03,the soreness of waist scores were 1.31±1.19 and 0.72±1.00,the morning diarrhea scores were 0.28±0.74 and 0.19±0.61,the anaphrodisia scores were 0.65±1.13 and 0.53±0.98,the low spirits scores were 0.29±0.81 and 0.08±0.40,the cold limbs score were 1.09±1.20 and 0.55±0.93,the edema scores were 0.14±0.55 and 0.05±0.30,the bright pale complexion scores were 0.20±0.59 and 0.24±0.65,respectively.There were significant differences in the reduction of each symptom score between the two groups(P<0.05);the 56-day group had a more significant decrease in the score of cold limbs than the 84-day group.The remaining symptom scores decreased more significantly in the 84-day group.After treatment,the syndrome scores of kidney-yang deficiency syndrome in the two groups were significantly lower than those before treatment(all P<0.05);the change rates of score in the 56-day group and the 84-day group were(-72.33±24.57)%and(-78.77±19.53)%,respectively,and the difference was statistically significant(P<0.05).The self-reported time to first symptom relief was(14.85±7.18)days in the 56-day group and(14.10±7.78)days in the 84-day group,with no significant difference(P>0.05).The incidence of adverse reactions of Shenbao tablets was 5.37%,mainly reflected in hepatobiliary system diseases,gastrointestinal system diseases and various examination abnormalities.Conclusions After taking Shenbao tablets for 2 to 3 months,the clinical symptoms of kidney-yang deficiency were better improved,and the improvement was more significant after 3 months of treatment.The security of Shenbao Tablets was good.

Result Analysis
Print
Save
E-mail